Cryo-Cell International(CCEL) - 2024 Q3 - Quarterly Report

U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.01 par value CCEL NYSE American LLC Non-accelerated filer ☑ Smaller reporting company ☑ FORM 10-Q (Mark One) ☒ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended August 31, 2024 ☐ Transition report pursuant to Section 13 or ...